Zura Bio Correlations
ZURA Stock | 1.28 0.05 3.76% |
The current 90-days correlation between Zura Bio Limited and Codexis is 0.05 (i.e., Significant diversification). The correlation of Zura Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Zura Bio Correlation With Market
Good diversification
The correlation between Zura Bio Limited and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and DJI in the same portfolio, assuming nothing else is changed.
Zura |
Moving together with Zura Stock
0.69 | TERN | Terns Pharmaceuticals | PairCorr |
0.61 | CRNX | Crinetics Pharmaceuticals Earnings Call Tomorrow | PairCorr |
0.85 | CTMX | CytomX Therapeutics | PairCorr |
0.83 | EMBC | Embecta Corp | PairCorr |
Moving against Zura Stock
0.46 | OPT | Opthea Earnings Call Tomorrow | PairCorr |
0.37 | GANX | Gain Therapeutics | PairCorr |
0.35 | LTRN | Lantern Pharma | PairCorr |
0.34 | PHGE | Biomx Inc | PairCorr |
0.37 | ELV | Elevance Health | PairCorr |
0.61 | EC | Ecopetrol SA ADR Earnings Call Tomorrow | PairCorr |
0.59 | OBI | Ondine Biomedical | PairCorr |
0.53 | WPM | Wheaton Precious Metals | PairCorr |
0.48 | T | ATT Inc Aggressive Push | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Zura Stock performing well and Zura Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zura Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
UAN | 1.20 | 0.16 | 0.11 | (6.05) | 1.14 | 3.38 | 12.05 | |||
HIHO | 0.99 | (0.01) | (0.01) | (0.13) | 1.41 | 2.69 | 8.40 | |||
SXT | 1.11 | (0.13) | 0.00 | (0.12) | 0.00 | 1.92 | 11.22 | |||
GFF | 1.38 | (0.23) | 0.00 | (0.15) | 0.00 | 2.23 | 12.08 | |||
BAK | 2.73 | (0.27) | 0.00 | (0.26) | 0.00 | 5.61 | 20.47 | |||
PPG | 1.12 | (0.11) | 0.00 | (0.14) | 0.00 | 2.56 | 8.61 | |||
HNI | 1.32 | (0.28) | 0.00 | (0.18) | 0.00 | 3.19 | 8.91 | |||
CDXS | 3.03 | (0.18) | 0.00 | (0.51) | 0.00 | 7.51 | 23.04 |
Zura Bio Corporate Management
Gary Whale | Chief Officer | Profile | |
David Brady | Head Development | Profile | |
Kiran MBBS | Chief Development | Profile | |
Kimberly Davis | Chief Secretary | Profile | |
Theresa Lowry | Chief Officer | Profile | |
Verender Badial | Chief Officer | Profile | |
Michael Howell | Chief Medicine | Profile |